Product Details
| Product Name: Medroxyprogesterone Acetate | CAS No.: 71-58-9 |
| Min. Order: 1kg | Purity: 99% |
| Supply Ability: 800kg | Release date: 2025/12/25 |
Medroxyprogesterone Acetate | GMP-Certified USP/EP Grade Hormone API? ??
Contraceptive & Oncology Applications with ≥99% Purity
?? ?Product Overview?
Medroxyprogesterone Acetate is a synthetic progestin widely used in hormonal contraceptives, oncology therapies, and hormone replacement treatments?12. It regulates progesterone receptors to inhibit ovulation and suppress estrogen-dependent tumor growth?14. Suitable for ?oral tablets?, ?injectables?, and ?implantable devices?, it meets ?pharmaceutical-grade? standards for precision and safety?12.
? ?Key Advantages?
| ?≥99% HPLC Purity? | Complies with ?USP/EP? pharmacopeia standards?12 |
| ?Stable Formulation? | Maintains potency for ?24 months? under controlled storage?14 |
| ?Low Residual Solvents? | ≤10 ppm (ICH Q3C compliant)?12 |
| ?Non-GMO & Halal Certified? | Global regulatory compliance for diverse markets?24 |
?? ?Applications?
- ?Contraceptives?
: Long-acting injectables (e.g., Depo-Provera?) and oral formulations?14.
- ?Oncology?
: Adjunctive therapy for endometrial and renal cancers?24.
- ?Gynecological Disorders?
: Treatment of endometriosis and abnormal uterine bleeding?12.
- ?Hormone Replacement Therapy (HRT)?
: Menopause symptom management?14.
?? ?Quality Certifications?
Manufactured under ?GMP?, ?ISO 9001?, and ?WHO? guidelines? .
Tested via HPLC?, ?GC-MS?, and ?residual solvent analysis?.
Compliant with ?FDA 21 CFR?and ?EU GMP Annex 1?.
?? ?Market Trends?
The global hormonal contraceptives market is projected to reach ?$23.7B by 2030?, driven by rising demand for long-acting reversible contraceptives?24. Oncology applications of progestins are growing at ?6.8% CAGR?, supported by advancements in targeted cancer therapies?14.
Company Profile Introduction
You may like
-
CAS:302-23-8
-
CAS:595-33-5
-
CAS:2919-66-6
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP2Y
|
Xi an Biohorlden Industry Trade Co Ltd
|
2026-06-25 | ||
| $100.00 |
VIP2Y
|
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
|
2026-06-25 | |
| $1.00 |
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-06-25 | |
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-06-24 | ||
|
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2026-06-23 | ||
|
VIP5Y
|
Sinoway Industrial co., ltd.
|
2026-06-22 | ||
| $29.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-05-12 | |
| $29.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-05-12 | |
| $85.00 |
VIP3Y
|
Zibo Hangyu Biotechnology Development Co., Ltd
|
2026-05-05 | |
|
CHONGQING CHENCHENG PHARMACEUTICAL CO.，LTD.
|
2026-01-19 |
China+86-+undefined-+86 13343427080
sales@biocarchem.com